Skip to main content
search
Menu
Home
About
News
Resources
Events
FAQ & Support
Programs
Laws and Regulations Governing Buprenorphine for OUD
Managing the Legal Risks of Prescribing Controlled Medications
Preparing for and Responding to DEA Visits
Prescribing Buprenorphine for OUD During a Public Health Emergency
search
Search
Close Search
All Posts By
admin
FDA Recommends Discussing Naloxone When Prescribing Opioids
July 23, 2020
Drug Overdose Deaths Up 4.6% in 2019
July 16, 2020
DOJ Targets Pain Management Specialists
July 4, 2020
Pandemic Unleashes a Spike in Overdoses, Deaths
June 29, 2020
PAINWeek 2020
June 11, 2020
2020 Pain Care Legislation and Public Policy Webinar
June 10, 2020
Rx Summit 2020
April 14, 2020
COVID-19: OUD Practice and Policy Considerations
April 3, 2020
Preparing for and Responding to DEA Visits
March 25, 2020
Prescribing Buprenorphine via Telemedicine During a Public Health Emergency
March 18, 2020
More
Close Menu
Home
About
News
Resources
Events
FAQ & Support
Programs
Laws and Regulations Governing Buprenorphine for OUD
Managing the Legal Risks of Prescribing Controlled Medications
Preparing for and Responding to DEA Visits
Prescribing Buprenorphine for OUD During a Public Health Emergency
